{
    "hands_on_practices": [
        {
            "introduction": "Continuous antibiotic prophylaxis (CAP) is a key strategy in managing children with vesicoureteral reflux to prevent the morbidity of febrile urinary tract infections. This practice requires precise, weight-based dosing and careful consideration of renal function to maximize safety and efficacy. This problem provides a practical exercise in calculating appropriate dosages for common prophylactic agents and applying critical renal adjustment criteria, a fundamental skill in pediatric pharmacology .",
            "id": "5217185",
            "problem": "A child with Vesicoureteral Reflux (VUR) weighing $15\\,\\mathrm{kg}$ is placed on once-daily urinary tract infection prophylaxis. Two commonly used agents are Trimethoprim-Sulfamethoxazole (TMP-SMX) and nitrofurantoin. For TMP-SMX, the prophylactic dose is specified as $2\\,\\mathrm{mg/kg}$ of the trimethoprim component once daily. For nitrofurantoin, the prophylactic dose is $1.5\\,\\mathrm{mg/kg}$ once daily. The child’s estimated Glomerular Filtration Rate (eGFR) is $40\\,\\mathrm{mL/min/1.73\\,m^{2}}$. Use the following well-tested pharmacotherapeutic facts as the fundamental base for your reasoning:\n- In pediatric weight-based dosing, the administered mass scales linearly with body mass.\n- Renal dosing adjustments are indicated when renal clearance is reduced. For TMP-SMX, no dose reduction is recommended when the eGFR is at least $30\\,\\mathrm{mL/min/1.73\\,m^{2}}$. For nitrofurantoin, use is generally avoided if eGFR is less than $30\\,\\mathrm{mL/min/1.73\\,m^{2}}$; no dose reduction is recommended when eGFR is at least $30\\,\\mathrm{mL/min/1.73\\,m^{2}}$.\n\nAssuming both agents were (counterfactually) prescribed concurrently, calculate the combined adjusted daily mass that would be administered under these renal function conditions. Round your answer to four significant figures. Express the final mass in milligrams (mg).",
            "solution": "The problem is validated as scientifically grounded, well-posed, and free of contradictions. The provided data are sufficient and consistent for a unique solution. The question is a straightforward application of pharmacotherapeutic principles involving weight-based dosing and renal function adjustments.\n\nThe task is to calculate the combined daily mass of two prophylactic agents, Trimethoprim-Sulfamethoxazole (TMP-SMX) and nitrofurantoin, for a child with specified weight and renal function. The problem explicitly states that the concurrent prescription is a counterfactual assumption for the purpose of this calculation.\n\nFirst, we identify the given parameters:\nChild's body mass, $m_{child} = 15\\,\\mathrm{kg}$.\nProphylactic dose rate of the trimethoprim component of TMP-SMX, $D_{TMP-SMX} = 2\\,\\mathrm{mg/kg}$ per day.\nProphylactic dose rate of nitrofurantoin, $D_{Nito} = 1.5\\,\\mathrm{mg/kg}$ per day.\nChild's estimated Glomerular Filtration Rate, $eGFR = 40\\,\\mathrm{mL/min/1.73\\,m^{2}}$.\n\nNext, we must assess the need for dose adjustments based on the child's renal function. The problem provides the following criteria:\nFor TMP-SMX, no dose reduction is recommended when $eGFR$ is at least $30\\,\\mathrm{mL/min/1.73\\,m^{2}}$.\nFor nitrofurantoin, no dose reduction is recommended when $eGFR$ is at least $30\\,\\mathrm{mL/min/1.73\\,m^{2}}$.\n\nThe child's $eGFR$ is given as $40\\,\\mathrm{mL/min/1.73\\,m^{2}}$. We compare this value to the specified thresholds.\nFor TMP-SMX: Since $40\\,\\mathrm{mL/min/1.73\\,m^{2}} \\ge 30\\,\\mathrm{mL/min/1.73\\,m^{2}}$, no dose adjustment is required.\nFor nitrofurantoin: Since $40\\,\\mathrm{mL/min/1.73\\,m^{2}} \\ge 30\\,\\mathrm{mL/min/1.73\\,m^{2}}$, no dose adjustment is required. The contraindication for $eGFR < 30\\,\\mathrm{mL/min/1.73\\,m^{2}}$ is not applicable here.\n\nTherefore, we can calculate the daily mass for each drug using the standard weight-based dosing formulas.\n\nLet $M_{TMP-SMX}$ be the daily mass of the trimethoprim component. This is calculated by multiplying the dose rate by the child's mass:\n$$M_{TMP-SMX} = D_{TMP-SMX} \\times m_{child}$$\n$$M_{TMP-SMX} = (2\\,\\mathrm{mg/kg}) \\times (15\\,\\mathrm{kg}) = 30\\,\\mathrm{mg}$$\n\nLet $M_{Nito}$ be the daily mass of nitrofurantoin. This is calculated similarly:\n$$M_{Nito} = D_{Nito} \\times m_{child}$$\n$$M_{Nito} = (1.5\\,\\mathrm{mg/kg}) \\times (15\\,\\mathrm{kg}) = 22.5\\,\\mathrm{mg}$$\n\nThe problem asks for the combined adjusted daily mass, which we denote as $M_{total}$. This is the sum of the individual masses:\n$$M_{total} = M_{TMP-SMX} + M_{Nito}$$\n$$M_{total} = 30\\,\\mathrm{mg} + 22.5\\,\\mathrm{mg} = 52.5\\,\\mathrm{mg}$$\n\nThe problem requires the answer to be rounded to four significant figures. The calculated value $52.5$ has three significant figures. To express this with four significant figures, we add a trailing zero.\n$$M_{total} = 52.50\\,\\mathrm{mg}$$",
            "answer": "$$\\boxed{52.50}$$"
        },
        {
            "introduction": "When surgical correction of VUR is indicated, the goal of ureteral reimplantation is to create a competent valve mechanism. While surgeons often use a target length-to-diameter ratio, such as $L:D=5$, as a guide, true mastery lies in understanding the underlying biomechanics. This exercise challenges you to move beyond simple geometry and use physical principles to explain why the bladder's structural support is just as crucial for creating a functional antireflux valve .",
            "id": "5217204",
            "problem": "A child with chronic high-grade vesicoureteral reflux (VUR) is scheduled for ureteral reimplantation. Intraoperative hydrodistention and measurement yield a ureteral diameter of $6$ millimeters (mm). The surgeon aims to construct a submucosal tunnel such that the length-to-diameter ratio $L:D$ equals $5$, a widely accepted geometric target for competence in antireflux reimplantation. Using only the given diameter and target ratio, compute the required submucosal tunnel length. Express your answer in millimeters (mm) and round to $3$ significant figures.\n\nThen, starting from first principles that define competence as the state in which external compressive forces exceed internal distending forces along the intramural segment, and using well-tested physical reasoning for thin-walled tubes (Laplace’s law for wall tension), explain how insufficient detrusor muscle backing could undermine competence even when the geometric target $L:D=5$ is met.",
            "solution": "The problem is evaluated to be scientifically grounded, well-posed, and objective. It is based on established principles in both surgery and biomechanics. The quantitative part is a direct application of a given ratio, and the conceptual part requires a logical explanation derived from a specified physical law. The problem is therefore valid.\n\nThe problem consists of two parts: a calculation and a conceptual explanation.\n\n**Part 1: Calculation of Submucosal Tunnel Length**\n\nThe problem provides the following given quantities:\n1.  The ureteral diameter, $D = 6$ mm.\n2.  The target length-to-diameter ratio, which can be expressed as the equation $\\frac{L}{D} = 5$.\n\nThe objective is to compute the required submucosal tunnel length, $L$. We can rearrange the given equation to solve for $L$:\n$$L = 5 \\times D$$\n\nSubstituting the given value for the diameter, $D = 6$ mm, we obtain the length:\n$$L = 5 \\times 6 \\, \\text{mm} = 30 \\, \\text{mm}$$\n\nThe problem requires the answer to be expressed in millimeters and rounded to $3$ significant figures. To express the integer $30$ with three significant figures, we write it as $30.0$.\n\nThus, the required submucosal tunnel length is $30.0$ mm.\n\n**Part 2: Conceptual Explanation of Competence Failure**\n\nThe problem requires an explanation, based on first principles and Laplace's law, for how insufficient detrusor muscle backing can lead to the failure of the antireflux mechanism, even when the surgical geometry ($L:D = 5$) is correct.\n\nThe fundamental principle of ureterovesical competence is that the intramural segment of the ureter functions as a passive flap valve. This valve mechanism prevents the retrograde flow of urine from the bladder into the ureter (vesicoureteral reflux), particularly when the pressure inside the bladder ($P_{\\text{ves}}$) is high, such as during filling or micturition (voiding).\n\nCompetence is achieved when the total external compressive force on the submucosal ureter exceeds the total internal distending force. The external compressive force is generated by the intravesical pressure, $P_{\\text{ves}}$, acting upon the outer surface of the ureter. For this force to effectively collapse the ureteral lumen, the ureter must be compressed against a firm, unyielding surface. This firm surface is the detrusor muscle of the bladder wall, which serves as a \"backing plate.\" The total compressive force, $F_{\\text{comp}}$, is proportional to the bladder pressure and the area over which it acts, which is related to the tunnel length $L$ and diameter $D$: $F_{\\text{comp}} \\propto P_{\\text{ves}} \\cdot L \\cdot D$.\n\nThe internal distending force arises from the urine pressure within the ureter, $P_{\\text{urine}}$, and the intrinsic stiffness of the ureteral wall. Laplace's law for a thin-walled cylinder provides a model for this relationship. In this context, it describes the internal pressure required to keep the lumen open against external pressure. The hoop tension ($\\sigma_h$) in the ureteral wall resists collapse. For a cylinder of radius $R = D/2$, the transmural pressure $\\Delta P = P_{\\text{int}} - P_{\\text{ext}}$ is balanced by wall tension. For the lumen to be held open, the internal pressure must generate sufficient wall tension to resist the external compressive pressure.\n\nThe surgical construction of a submucosal tunnel with a length-to-diameter ratio $L:D \\ge 5$ is designed to ensure that the surface area for compression is large enough. A longer tunnel ($L$) increases the total compressive force for a given bladder pressure, enhancing the effectiveness of the flap-valve mechanism. This ensures that as $P_{\\text{ves}}$ rises, the ureter is reliably sealed.\n\nThe critical flaw introduced by \"insufficient detrusor muscle backing\" is the failure of the \"backing plate.\" If the detrusor muscle behind the reimplanted ureter is weak, thin, scarred, or otherwise deficient (as might occur in a bladder diverticulum or in certain neuropathic states), it cannot provide the necessary rigid support.\n\nWhen bladder pressure $P_{\\text{ves}}$ increases, instead of compressing the ureter against a firm wall, the pressure acts on both the ureter and the pliable tissue behind it. The weak backing yields and bulges outwards along with the ureter. Consequently, the effective pressure differential across the ureteral wall, which is necessary for coaptation (flattening and sealing) of its lumen, is not achieved. The external pressure is not efficiently converted into a compressive force on the ureter.\n\nThis can be analogized to attempting to flatten a flexible tube. Stepping on the tube while it is on a hard surface like concrete (analogous to healthy detrusor) will easily collapse it. Stepping on the same tube when it is on soft mud (analogous to insufficient backing) will simply push the tube into the mud without collapsing it.\n\nIn summary, even if the surgeon achieves the ideal geometric ratio of $L:D = 5$, the antireflux mechanism will be undermined if the detrusor backing is inadequate. The correct geometry is a necessary but not sufficient condition for competence. The functional integrity of the surrounding bladder wall is equally critical to provide the firm support required for the passive flap-valve mechanism to work. Without this support, the external compressive forces are dissipated, the ureteral lumen remains patent, and reflux persists.",
            "answer": "$$\\boxed{30.0}$$"
        },
        {
            "introduction": "Clinical practice often presents complex scenarios where initial diagnoses and treatments do not fully resolve a patient's symptoms. In this advanced case, febrile urinary tract infections persist even after vesicoureteral reflux has been successfully corrected, signaling an underlying or co-existing pathology. This problem will test your ability to synthesize clinical data, broaden your differential diagnosis to include conditions like bladder-bowel dysfunction, and formulate an appropriate plan for further investigation .",
            "id": "5217206",
            "problem": "A child presents to the pediatric urology clinic with recurrent febrile urinary tract infections despite documented resolution of vesicoureteral reflux. A $5$-year-old girl had primary bilateral vesicoureteral reflux (defined as retrograde urine flow from bladder into ureter and kidney during filling or voiding) graded II–III on voiding cystourethrogram (VCUG) at age $4$ years. Eight months ago, she underwent endoscopic injection with dextranomer/hyaluronic acid copolymer (Dx/HA), and a post-procedural VCUG at $3$ months demonstrated no reflux. Over the past $6$ months, she has had $3$ culture-proven febrile urinary tract infections with Escherichia coli sensitive to third-generation cephalosporins but resistant to trimethoprim-sulfamethoxazole. She is not sexually active. Parents report daytime urgency, infrequent voiding (approximately $3$ times per day), holding maneuvers, and hard stools consistent with constipation. Physical examination reveals palpable stool in the left lower quadrant and mild suprapubic tenderness; neurologic examination, including lower extremity tone, perineal sensation, and reflexes, is normal, with no cutaneous stigmata over the lumbosacral spine. Renal-bladder ultrasonography (RBUS) shows normal renal size and parenchyma with new mild right-sided hydronephrosis (Society for Fetal Urology grade I), bladder wall thickening, and a post-void residual of approximately $70$ mL measured by ultrasound. Serum creatinine and blood pressure are normal. \n\nGrounded in the following foundational facts:\n- Bacterial urinary tract infections commonly arise via ascending periurethral colonization; efficient bladder emptying and low intravesical pressures reduce risk by limiting residual urine and reflux of infected urine.\n- Vesicoureteral reflux (VUR) increases risk of pyelonephritis by facilitating ascent of infected urine to the upper tract; however, recurrent febrile infections after documented resolution of VUR prompt evaluation for alternative mechanisms such as bladder-bowel dysfunction, anatomical or iatrogenic obstruction, and host defense abnormalities.\n- Expected functional bladder capacity in children can be approximated by widely accepted pediatric urology nomograms; one commonly used estimate is $ \\text{Capacity (mL)} \\approx (\\text{age (years)} \\times 30) + 30 $.\n- Diuretic renography with Technetium-$^{99\\text{m}}$ mercaptoacetyltriglycine (MAG3) can objectively assess differential renal function and drainage to detect obstruction.\n- Uroflowmetry with pelvic floor electromyography (EMG), post-void residual measurement, voiding diaries, and constipation assessment are standard tools to diagnose bladder-bowel dysfunction.\n\nWhich of the following are the most appropriate next evaluations to investigate etiologies beyond reflux that plausibly account for this child’s recurrent febrile urinary tract infections? Select ALL that apply.\n\nA. Comprehensive bladder-bowel dysfunction assessment including uroflowmetry with pelvic floor electromyography, repeat post-void residual measurements across multiple voids, a structured voiding diary, and targeted constipation evaluation with initiation of a bowel regimen.\n\nB. Immediate reinstatement of continuous broad-spectrum antibiotic prophylaxis indefinitely without further diagnostic work-up, given recurrent febrile infections.\n\nC. Immediate repeat voiding cystourethrogram to search for recurrent low-grade reflux despite prior documented resolution, as the first-line test.\n\nD. Diuretic renography (Technetium-$^{99\\text{m}}$ MAG3) to evaluate for ureterovesical junction obstruction potentially induced by dextranomer/hyaluronic acid injection, given the new mild hydronephrosis and recurrent febrile infections.\n\nE. Immunologic work-up including quantitative immunoglobulins (IgG, IgA, IgM), total hemolytic complement, and neutrophil oxidative burst testing for chronic granulomatous disease, based on the recurrence despite appropriate therapy.\n\nF. Spinal magnetic resonance imaging of the lumbosacral spine to evaluate for an occult tethered cord despite normal neurologic examination and lack of cutaneous stigmata.",
            "solution": "The problem statement is subjected to validation before proceeding to a solution.\n\n### Step 1: Extract Givens\n- **Patient Profile:** A $5$-year-old girl.\n- **Presenting Complaint:** Recurrent febrile urinary tract infections (UTIs).\n- **Past Medical History:** Primary bilateral vesicoureteral reflux (VUR), grade II–III, diagnosed at age $4$ years.\n- **Past Surgical History:** Endoscopic injection with dextranomer/hyaluronic acid copolymer (Dx/HA) $8$ months ago.\n- **Follow-up Data:** A post-procedural voiding cystourethrogram (VCUG) at $3$ months post-procedure demonstrated no reflux.\n- **Interval History:** Over the past $6$ months, she has had $3$ culture-proven febrile UTIs with Escherichia coli sensitive to third-generation cephalosporins but resistant to trimethoprim-sulfamethoxazole.\n- **Social History:** Not sexually active.\n- **Reported Symptoms:** Daytime urgency, infrequent voiding (approximately $3$ times per day), holding maneuvers, and hard stools consistent with constipation.\n- **Physical Examination:** Palpable stool in the left lower quadrant; mild suprapubic tenderness; normal neurologic examination (lower extremity tone, perineal sensation, and reflexes); no cutaneous stigmata over the lumbosacral spine.\n- **Imaging:** Renal-bladder ultrasonography (RBUS) shows normal renal size and parenchyma with new mild right-sided hydronephrosis (Society for Fetal Urology grade I), bladder wall thickening, and a post-void residual (PVR) of approximately $70$ mL.\n- **Laboratory Data:** Serum creatinine and blood pressure are normal.\n- **Foundational Fact 1:** Efficient bladder emptying and low intravesical pressures reduce UTI risk.\n- **Foundational Fact 2:** Recurrent febrile UTIs after VUR resolution prompt evaluation for alternative mechanisms such as bladder-bowel dysfunction (BBD), obstruction, and host defense abnormalities.\n- **Foundational Fact 3:** Expected bladder capacity in children (mL) $\\approx \\text{age (years)} \\times 30 + 30$.\n- **Foundational Fact 4:** Diuretic renography with Technetium-$^{99\\text{m}}$ mercaptoacetyltriglycine (MAG3) assesses differential renal function and drainage to detect obstruction.\n- **Foundational Fact 5:** Uroflowmetry with pelvic floor electromyography (EMG), PVR measurement, voiding diaries, and constipation assessment are standard tools to diagnose BBD.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is well-defined and internally consistent.\n- **Scientifically Grounded:** The clinical scenario is a classic presentation in pediatric urology. The pathophysiology described, diagnostic modalities mentioned, and the principles provided are all rooted in established medical science.\n- **Well-Posed:** The problem provides sufficient, relevant data to allow for a reasoned decision on the most appropriate next steps in diagnosis. The question is specific and answerable.\n- **Objective:** The presentation is objective, using precise clinical terminology and reporting quantitative findings (e.g., PVR of $70$ mL, $3$ UTIs in $6$ months).\n- **Completeness and Consistency:** The data are complete and consistent. The history of VUR and its treatment, followed by recurrent UTIs, coupled with new symptoms and ultrasound findings, creates a coherent clinical puzzle. There are no contradictions. The provided foundational facts serve as axioms for solving the problem.\n\n### Step 3: Verdict and Action\nThe problem statement is valid. The solution process will now proceed.\n\n### Derivation of the Solution\nThe central clinical issue is the recurrence of febrile UTIs in a child whose VUR has been successfully treated, as documented by a post-procedural VCUG. According to the foundational facts, this situation mandates a search for alternative or co-existing etiologies. The clinical data point strongly toward two specific pathologies.\n\n**1. Bladder-Bowel Dysfunction (BBD):**\nThe evidence for BBD is compelling. The patient exhibits a classic symptom cluster:\n- **Bowel Dysfunction:** Constipation with hard stools and palpable stool on examination. A full rectum can mechanically compress the bladder, leading to incomplete emptying and sensory alteration.\n- **Bladder Dysfunction:** Symptoms include infrequent voiding (~$3$ times per day, which is low for a child), urgency, and holding maneuvers. These behaviors lead to bladder overdistension and high storage pressures.\n- **Objective Findings:** The RBUS reveals bladder wall thickening, which is indicative of chronic high-pressure storage or voiding against a poorly relaxed sphincter. Critically, the post-void residual (PVR) volume is $70$ mL. Using the provided formula, the expected bladder capacity (EBC) for a $5$-year-old is:\n$$ \\text{EBC} \\approx (5 \\times 30 + 30) \\text{ mL} = 180 \\text{ mL} $$\nA PVR of $70$ mL represents approximately $39\\%$ of her expected capacity ($70/180 \\approx 0.389$). A PVR greater than $20$ mL or $>10\\%$ of bladder capacity is generally considered abnormal. This degree of incomplete bladder emptying provides a static reservoir of urine, an ideal medium for bacterial proliferation, directly increasing the risk of UTI as per Foundational Fact 1.\n\n**2. Ureteral Obstruction:**\nThe RBUS shows \"new mild right-sided hydronephrosis.\" This is a significant finding that cannot be ignored, especially in the context of febrile UTIs. The patient underwent Dx/HA injection into the ureterovesical junction (UVJ) to correct VUR. A known, though uncommon, complication of this procedure is iatrogenic UVJ obstruction, where the injected bulk narrows the ureteral orifice, impeding urine flow from the kidney to the bladder. This leads to urine stasis in the upper tract (hydronephrosis) and predisposes the kidney to infection (pyelonephritis, i.e., febrile UTI). The concurrence of febrile UTIs and new hydronephrosis post-injection makes the evaluation for obstruction a high priority.\n\nBased on this analysis, the most appropriate next steps must address these two highly plausible etiologies.\n\n### Evaluation of Options\n\n**A. Comprehensive bladder-bowel dysfunction assessment including uroflowmetry with pelvic floor electromyography, repeat post-void residual measurements across multiple voids, a structured voiding diary, and targeted constipation evaluation with initiation of a bowel regimen.**\nThis option directly investigates the most evident pathology presented in the case: BBD. The listed components (uroflow/EMG, diaries, PVRs, constipation management) are the standard diagnostic and initial management tools, as per Foundational Fact 5. A formal assessment is necessary to characterize the specific type of dysfunction (e.g., overactive bladder, dysfunctional voiding, underactive bladder) and to guide targeted behavioral and medical therapy. Given the profound impact of BBD on UTI risk, this is an essential and highly appropriate next step.\n**Verdict: Correct.**\n\n**B. Immediate reinstatement of continuous broad-spectrum antibiotic prophylaxis indefinitely without further diagnostic work-up, given recurrent febrile infections.**\nThis approach is purely palliative and fails to address the underlying pathophysiology. While temporary prophylaxis might be considered as a bridging measure, instituting it \"indefinitely without further diagnostic work-up\" constitutes substandard medical practice. It allows the root causes (BBD and/or obstruction) to persist, potentially leading to progressive renal damage, and contributes to the development of antibiotic resistance. The pathogen is already resistant to one common prophylactic agent.\n**Verdict: Incorrect.**\n\n**C. Immediate repeat voiding cystourethrogram to search for recurrent low-grade reflux despite prior documented resolution, as the first-line test.**\nWhile VUR can recur after endoscopic treatment, a VCUG performed only $5$ months prior was negative. The clinical evidence for BBD and the new finding of hydronephrosis are far more compelling and point to different diagnoses. A VCUG is invasive and involves radiation exposure. It is not the most logical or highest-yield *first-line* test in this specific clinical context. Investigating BBD and the cause of the hydronephrosis takes clear precedence.\n**Verdict: Incorrect.**\n\n**D. Diuretic renography (Technetium-$^{99\\text{m}}$ MAG3) to evaluate for ureterovesical junction obstruction potentially induced by dextranomer/hyaluronic acid injection, given the new mild hydronephrosis and recurrent febrile infections.**\nThis option directly addresses the \"new mild right-sided hydronephrosis,\" a serious finding suggesting impaired urine drainage from the kidney. As per Foundational Fact 4, diuretic renography is the definitive non-invasive test to quantify renal function and drainage, thereby confirming or refuting the presence of a clinically significant obstruction. Given the history of Dx/HA injection, iatrogenic obstruction is a distinct possibility that must be evaluated urgently, as obstruction with infection can rapidly damage the kidney.\n**Verdict: Correct.**\n\n**E. Immunologic work-up including quantitative immunoglobulins (IgG, IgA, IgM), total hemolytic complement, and neutrophil oxidative burst testing for chronic granulomatous disease, based on the recurrence despite appropriate therapy.**\nWhile recurrent infections can be a sign of primary immunodeficiency, such a work-up is not indicated as a primary step here. The patient has a very clear set of localizing urological and gastrointestinal findings (BBD, potential obstruction) that are well-established, potent risk factors for UTIs. A systemic immune defect is much lower on the differential diagnosis. This work-up would only be considered if UTIs persist despite correction of all identified anatomic and functional abnormalities.\n**Verdict: Incorrect.**\n\n**F. Spinal magnetic resonance imaging of the lumbosacral spine to evaluate for an occult tethered cord despite normal neurologic examination and lack of cutaneous stigmata.**\nA neurogenic cause of bladder dysfunction (e.g., tethered cord syndrome) is a possibility in any child with voiding dysfunction. However, in this case, the neurologic examination is explicitly normal, and there are no cutaneous markers of spinal dysraphism. These findings make an occult neurogenic etiology far less likely than functional BBD, for which there is abundant positive evidence. An MRI is an expensive, resource-intensive test that requires sedation in a young child and is not warranted as a primary investigation in this setting.\n**Verdict: Incorrect.**",
            "answer": "$$\\boxed{AD}$$"
        }
    ]
}